Allogeneic transplantation successfully corrects immune defects, but not susceptibility to colitis, in a patient with nuclear factor-κB essential modulator.

Slides:



Advertisements
Similar presentations
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Advertisements

Endoplasmic reticulum stress influences bronchial asthma pathogenesis by modulating nuclear factor κB activation So Ri Kim, MD, PhD, Dong Im Kim, MS, Mi.
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Immune deficiency caused by impaired expression of nuclear factor-κB essential modifier (NEMO) because of a mutation in the 5′ untranslated region of.
Triggering of specific Toll-like receptors and proinflammatory cytokines breaks allergen- specific T-cell tolerance in human tonsils and peripheral blood 
Doina M. Racila, MD, Joel N. Kline, MD, MSc 
Plasmacytoid dendritic cell depletion in DOCK8 deficiency: Rescue of severe herpetic infections with IFN-α 2b therapy  Sevgi Keles, MD, Haifa H. Jabara,
The effects of upper respiratory infection on T-cell proliferation and steroid sensitivity of asthmatics  Elcio O. Vianna, MD, PhD, Jay Westcott, PhD,
Early-onset monocyte–B–natural killer–dendritic cells’ deficiency successfully treated with hematopoietic stem cell transplantation  Caterina Cancrini,
Advances in food allergy in 2015
Human nuclear factor κB essential modulator mutation can result in immunodeficiency without ectodermal dysplasia  Jordan S. Orange, MD, PhD, Ofer Levy,
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Toll-like receptor 7–induced naive human B-cell differentiation and immunoglobulin production  Mark C. Glaum, MD, PhD, Shilpi Narula, MD, Decheng Song,
B-cell receptor cross-linking delays activation-induced cytidine deaminase induction and inhibits class-switch recombination to IgE  Haifa H. Jabara,
Epicutaneous sensitization results in IgE-dependent intestinal mast cell expansion and food-induced anaphylaxis  Lisa M. Bartnikas, MD, Michael F. Gurish,
Imidazoquinoline Toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1–dependent.
Long-term immune reconstitution after matched unrelated hematopoietic stem cell transplantation for immunodeficiency  Vy Hong-Diep Kim, MD, Brenda Reid,
Is 9 more than 2 also in allergic airway inflammation?
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Imidazoquinoline Toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1–dependent.
Triggering of specific Toll-like receptors and proinflammatory cytokines breaks allergen- specific T-cell tolerance in human tonsils and peripheral blood 
Tolerance-like mediated suppression by mesenchymal stem cells in patients with dust mite allergy–induced asthma  Simi Kapoor, MD, Shyam A. Patel, PhD,
Toll-like receptor 9 suppression in plasmacytoid dendritic cells after IgE-dependent activation is mediated by autocrine TNF-α  John T. Schroeder, PhD,
Physician needs in health informatics: Just ask the docs
Gut microbiome variations during hematopoietic stem cell transplant in severe combined immunodeficiency  Jonathan P. Lane, MBBS, Christopher J. Stewart,
Comèl-Netherton syndrome defined as primary immunodeficiency
A focused parameter update: Hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor–associated angioedema 
Interleukin receptor-associated kinase-4 deficiency impairs Toll-like receptor–dependent innate antiviral immune responses  Douglas R. McDonald, MD, PhD,
Hematopoietic stem cell transplantation outcomes for 11 patients with dedicator of cytokinesis 8 deficiency  Waleed Al-Herz, MD, Julia I. Chu, MD, Jet.
Immune modulation by neuronal electric shock waves
Kristina Rueter, MD, Anderson P
Peter M. Wolfgram, MD, David B. Allen, MD 
Toll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activation  Esra.
William J. Calhoun, MD, Tmirah Haselkorn, PhD, Dave P
Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA 
Activin A is an acute allergen-responsive cytokine and provides a link to TGF-β– mediated airway remodeling in asthma  Christian Karagiannidis, MD, Gabriele.
β-Agonist enhances type 2 T-cell survival and accumulation
Toll-like receptor 2 is important for the TH1 response to cutaneous sensitization  Haoli Jin, MD, PhD, Lalit Kumar, PhD, Clinton Mathias, PhD, David Zurakowski,
Sabine Leisten, MSc, Michiko K
Roel P. Gazendam, MD, Annemarie van de Geer, MD, John L
Novel mutation in STXBP2 prevents IL-2–induced natural killer cell cytotoxicity  Rushani W. Saltzman, MD, Linda Monaco-Shawver, BA, Kejian Zhang, MD, MBA,
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
Allergic skin sensitization promotes eosinophilic esophagitis through the IL-33–basophil axis in mice  Nicholas Venturelli, BS, Willem S. Lexmond, MD,
Immune deficiency caused by impaired expression of nuclear factor-κB essential modifier (NEMO) because of a mutation in the 5′ untranslated region of.
Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted.
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
CC chemokine receptors CCR1 and CCR4 are expressed on airway mast cells in allergic asthma  Kawa Amin, PhD, Christer Janson, MD, PhD, Ilkka Harvima, MD,
Autoimmune lymphoproliferative syndrome caused by a homozygous FasL mutation that disrupts FasL assembly  Ali Sobh, MD, Elena Crestani, MD, Brittney Cangemi,
The L412F variant of Toll-like receptor 3 (TLR3) is associated with cutaneous candidiasis, increased susceptibility to cytomegalovirus, and autoimmunity 
Direct ex vivo analysis of allergen-specific CD4+ T cells
H. William Kelly, PharmD  Journal of Allergy and Clinical Immunology 
Autophagy: Nobel Prize 2016 and allergy and asthma research
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Amplification of Toll-like receptor–mediated signaling through spleen tyrosine kinase in human B-cell activation  Shigeru Iwata, MD, PhD, Kunihiro Yamaoka,
Matthew J. Loza, PhD, Susan Foster, PhD, Stephen P
The gastrointestinal tract is critical to the pathogenesis of acute HIV-1 infection  Saurabh Mehandru, MD, Klara Tenner-Racz, MD, Paul Racz, MD, PhD, Martin.
Improvement of treatment-refractory atopic dermatitis by immunoadsorption: A pilot study  Michael Kasperkiewicz, MD, Enno Schmidt, MD, PhD, Yvonne Frambach,
Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency  Marcel Levi, MD,
Jessica H. Savage, MD, MHS, Elizabeth C. Matsui, MD, MHS, Robert A
Heterozygous N-terminal deletion of IκBα results in functional nuclear factor κB haploinsufficiency, ectodermal dysplasia, and immune deficiency  Douglas.
The Editors' Choice Journal of Allergy and Clinical Immunology
CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X- linked–like syndrome, and defective IL-10 expression from CD4 lymphocytes 
A pilot study of equal doses of 10% IGIV given intravenously or subcutaneously  Shilpa H. Desai, BS, MD, Akhil Chouksey, MD, John Poll, RN, Melvin Berger,
Macrolide antibiotics and asthma treatment
Asthma: The past, future, environment, and costs
Severe cutaneous human papillomavirus infection associated with natural killer cell deficiency following stem cell transplantation for severe combined.
Interrupting IL-6–receptor signaling improves atopic dermatitis but associates with bacterial superinfection  Alexander A. Navarini, MD, PhD, Lars E.
Janet Chou, MD, Maxim Lutskiy, MD, PhD, Erdyni Tsitsikov, PhD, Luigi D
Natural history of cow’s milk allergy
Combined immunodeficiency in a patient with c-Rel deficiency
Presentation transcript:

Allogeneic transplantation successfully corrects immune defects, but not susceptibility to colitis, in a patient with nuclear factor-κB essential modulator deficiency  Sung-Yun Pai, MD, Ofer Levy, MD, PhD, Haifa H. Jabara, BS, Jonathan N. Glickman, MD, PhD, Liat Stoler-Barak, MS, Jessica Sachs, MD, Samuel Nurko, MD, Jordan S. Orange, MD, PhD, Raif S. Geha, MD  Journal of Allergy and Clinical Immunology  Volume 122, Issue 6, Pages 1113-1118.e1 (December 2008) DOI: 10.1016/j.jaci.2008.08.026 Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Clinical and histologic course of colitis after HSCT. A, Colonic biopsy specimens showing active colitis (before HSCT, 105 days after HSCT, and 20 months after HSCT), GVHD (105 days after HSCT; apoptosis is indicated by arrows in the inset), and resolution of both colitis and GVHD (30 months after HSCT). B, The dose of prednisolone equivalent is graphed as a function of time after HSCT with bacterial infections (arrows, B), relevant events, and treatments, as indicated. Journal of Allergy and Clinical Immunology 2008 122, 1113-1118.e1DOI: (10.1016/j.jaci.2008.08.026) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 A-C, Cytokine production in response to TLR ligands. TNF-α production is normalized relative to adult control subjects assessed within each experiment. Data represent the mean plus SD of 2 to 3 independent assays performed at 4 to 8 months after HSCT. MALP, Macrophage-activating lipopeptide; Poly I:C, polyinosinic:polycytidylic acid; ODN2216, oligodeoxynucleotide 2216. Journal of Allergy and Clinical Immunology 2008 122, 1113-1118.e1DOI: (10.1016/j.jaci.2008.08.026) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 Restoration of B-cell and NK cell function after HSCT. A, NK cell cytotoxicity. B, Proliferation of PBMCs to anti-CD40 plus IL-4 measured by means of incorporation of tritiated thymidine. Data are representative of 2 experiments performed at 8 to 9 months after HSCT. Journal of Allergy and Clinical Immunology 2008 122, 1113-1118.e1DOI: (10.1016/j.jaci.2008.08.026) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Cytokine production in response to TLR4 agonist Cytokine production in response to TLR4 agonist. TNF production is normalized relative to adult control cells assessed within each experiment. Data represent mean plus SD of 2 independent assays performed at approximately 45 months after HSCT. Journal of Allergy and Clinical Immunology 2008 122, 1113-1118.e1DOI: (10.1016/j.jaci.2008.08.026) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions